Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Recurrence
×
Ipilimumab
×
Clear all
Filters
3
NCT03138512
2024-12-18
CheckMate 914
Bristol-Myers Squibb
Phase 3
Completed
1,641 enrolled
21 charts